Clinical Trial Update: Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting completion of a pediatric study of Myocet (liposomal doxorubicin) in children with relapsed or refractory non-brainstem malignant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• Myocet (liposomal doxorubicin)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Malignant Glioma | Phase 1 | Status: COMPLETED